BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schubert JP, Gehlert J, Rayner CK, Roberts-Thomson IC, Costello S, Mangoni AA, Bryant RV. Antibiotic resistance of Helicobacter pylori in Australia and New Zealand: A systematic review and meta-analysis. J Gastroenterol Hepatol 2021;36:1450-6. [PMID: 33217029 DOI: 10.1111/jgh.15352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Grosso R, de-Paz M. Scope and Limitations of Current Antibiotic Therapies against Helicobacter pylori: Reviewing Amoxicillin Gastroretentive Formulations. Pharmaceutics 2022;14:1340. [DOI: 10.3390/pharmaceutics14071340] [Reference Citation Analysis]
2 Wang R, Wang Y, Lu Z, Jing J, Wang Z, He T, Tian M, Yuan Z, Cui Y, Rong W, Ma X, Zhao Y. Efficacy and Safety of Zuojin Pill for the Treatment of Chronic Nonatrophic Gastritis: A Randomized Active-Controlled Clinical Trial. Evid Based Complement Alternat Med 2022;2022:2266023. [PMID: 35432566 DOI: 10.1155/2022/2266023] [Reference Citation Analysis]
3 Choe Y, Kim JS, Choi HH, Kim DB, Park JM, Oh JH, Kim TH, Cheung DY, Chung WC, Kim BW, Kim SS. The Influence of Past Metronidazole Exposure on the Outcome of Helicobacter pylori Eradication. Front Microbiol 2022;13:857569. [PMID: 35401472 DOI: 10.3389/fmicb.2022.857569] [Reference Citation Analysis]
4 Dai J, Zhao J, Mao L, Hu Y, Lv B. Study on the value of antibiotic-resistant gene detection in Helicobacter pylori in China. Exp Ther Med 2022;23:228. [PMID: 35222705 DOI: 10.3892/etm.2022.11153] [Reference Citation Analysis]
5 Gunaratne AW, Hamblin H, Clancy A, Magat AJMC, Dawson MVM, Tu J, Borody TJ. Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections-Exploratory study. Helicobacter 2021;:e12830. [PMID: 34247436 DOI: 10.1111/hel.12830] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]